Hyaluronidase for finger stiffness in scleroderma
Part of Immune system & allergy, Skin clinical trials.
This trial tests whether an injected enzyme called hyaluronidase can soften and loosen tight skin on the fingers caused by scleroderma, which may improve flexibility and comfort.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 59 years old.
- You have a diagnosis of scleroderma (systemic sclerosis).
- You have hardened or tight skin on your fingers (sclerodactyly).
- You are not pregnant or breastfeeding.
- You have no known allergy to hyaluronidase.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how systemic sclerosis (a condition that can cause hardening of the skin) affects hand function. It aims to understand the problems people face and find better ways to help.
This Phase 2 study tests whether injections under the skin can help heal painful, poor-circulation (ischemic) finger ulcers caused by scleroderma. It is for people whose ulcers have not improved with usual care.
This trial tests a cell-based treatment (mesenchymal stromal cells) to help heal painful finger/toe ulcers in people with systemic sclerosis. It is for ulcers that did not improve after a specific IV medicine called prostacyclins.
This trial tests a new cell injection treatment (RY_SW01) for people with systemic sclerosis (a condition causing skin thickening and organ issues). It aims to see if the therapy can improve skin hardening and overall symptoms.
This early-stage trial tests an investigational cell therapy for people with systemic sclerosis (scleroderma). The treatment uses your own modified immune cells to try to calm the overactive immune system and slow the disease, with imaging to see where the cells go in your body.
This study tests whether a person's own fat cells (processed into regenerative cells) can be injected into the hands to improve hand function and reduce skin thickening in systemic sclerosis (scleroderma). It’s designed for people whose hand problems are significant but not too severe.
Hear when a new Systemic Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.